Analysis of data from the Veterans Administration Central Cancer Registry, reported in the Journal of Clinical Oncology by Sanfilippo et al, showed that statin use was associated with a reduced risk of all-cause and multiple myeloma–specific mortality in patients with multiple myeloma. Statins are active in a pathway affected by nitrogen-containing bisphosphonates, which have been associated with improved survival in multiple myeloma.
The ASCO Post